Insider Shareholders with Direct Ownership of Verrica Pharmaceuticals Inc. (VRCA)
This section provides a comprehensive overview of the insiders with direct ownership of Verrica Pharmaceuticals Inc. (VRCA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Verrica Pharmaceuticals Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 23,438,870 | 450,000 | 25,828,094 $205 Million | 6 |
Nov 26, 2024
Reduced 1.71%
|
|
| 1,411,690 | 0 | 1,873,800 $14.9 Million | 3 |
Nov 26, 2024
Added 2.6%
|
|
|
Jayson Rieger
CEO and President |
330,898 | 0 | 882,826 $7.02 Million | 2 |
Nov 26, 2024
Added 5.36%
|
|
Ted White
PRESIDENT AND CEO |
365,309 | 150,999 | 215,967 $1.72 Million | 12 |
Aug 27, 2024
Reduced 4.01%
|
|
Christopher G. Hayes
CHIEF LEGAL OFFICER |
230,714 | 124,941 | 105,773 $840,895 | 13 |
Aug 27, 2024
Reduced 8.27%
|
|
Gary Goldenberg
Chief Medical Officer |
163,809 | 69,548 | 94,261 $749,374 | 11 |
Aug 27, 2024
Reduced 3.68%
|
|
Joe Bonaccorso
CHIEF COMMERCIAL OFFICER |
202,500 | 130,386 | 73,114 $581,256 | 10 |
Aug 27, 2024
Reduced 10.95%
|
|
John J. Kirby
Interim CFO |
54,267 | 0 | 54,267 $431,422 | 1 |
Nov 06, 2024
Added 50.0%
|
|
Terry Kohler
CHIEF FINANCIAL OFFICER |
102,500 | 57,803 | 44,697 $355,341 | 6 |
Aug 27, 2024
Reduced 15.02%
|
|
A Brian Davis
Chief Financial Officer |
5,000 | 0 | 12,900 $102,555 | 1 |
Jun 04, 2021
Added 27.93%
|